Selected Publications

Vaikunth S, Sundaravel S, Saef J, Ortega-Legaspi J: Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices. Curr Heart Fail Rep?�
August 2023.

Lerman JB, Green CL, Molina MR, Maharaj V, Ortega-Legaspi JM, Sen S, Flattery M, Maziarz EK, Shah KB, Martin CM, Alexy T, Shah P, Morris AA, DeVore AD, Cole RT.: Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation. Clin Transplant July 2023.

Saef J, Sundaravel S, Ortega-Legaspi J, Vaikunth S.: Safety and Treatment Experience with Sodium/glucose Cotransporter-2 Inhibitors (SGLT2i) in Adult Patients with Congenital Heart Disease.
 J Card Fail Mar 2023.

Juan M Ortega-Legaspi: Miocardiopatias. Cardiologia para medicos no especialistas. Ursulo Juarez Herrera (eds.). PyDESA, 2023.

Ortega-Legaspi JM, Molina M, Leon J, Cunningham A, Guerraty M, Peyster E, Julien H, McLean R, Goldberg L, Bravo PE. : Coronary Flow Reserve is an Independent Predictor of Major Adverse Cardiovascular Events in Long Term Heart Transplantation Survivors. The Journal of Heart and Lung Transplantation. ISHLT annual meeting.Denver, CO, USA. April 2023. 2023.

Juan M Ortega-Legaspi: Trasplante Cardiaco. Cardiologia para medicos no especialistas. Ursulo Juarez Herrera (eds.). PyDESA, 2023.

Juan M Ortega-Legaspi: Insuficiencia cardiaca: tratamiento contemporaneo. Cardiologia para medicos no especialistas. Ursulo Juarez Herrera (eds.). PyDESA, 2023.

Durgin JS, Jariwala NN, Rook AH, Ortega-Legaspi JM.: Reversible Cardiomyopathy after Interferon-Gamma for Cutaneous T Cell Lymphoma: A Report of Two Cases. Current Problems in Cancer: Case Reports 2023.

20. Chirinos JA, Lopez-Jaramillo P, Giamarellos-Bourboulis EJ, Dávila-Del-Carpio GH, Bizri AR, Andrade-Villanueva JF, Salman O, Cure-Cure C, Rosado-Santander NR, Cornejo Giraldo MP, González-Hernández LA, Moghnieh R, Angeliki R, Cruz Saldarriaga ME, Pariona M, Medina C, Dimitroulis I, Vlachopoulos C, Gutierrez C, Rodriguez-Mori JE, Gomez-Laiton E, Cotrina Pereyra R, Ravelo Hernández JL, Arbañil H, Accini-Mendoza J, Pérez-Mayorga M, Milionis C, Poulakou G, Sánchez G, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-García RJ, Castro-Callirgos CA, Alfaro Carrasco RM, Garrido Lecca Danos W, Sharkoski T, Greene K, Pourmussa B, Greczylo C, Ortega-Legaspi J, Jacoby D, Chittams J, Katsaounou P, Alexiou Z, Sympardi S, Sweitzer NK, Putt M, Cohen JB; FERMIN Investigators.: A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019. Nat Metab. 2022 Dec;4(12):1847-1857. doi: 10.1038/s42255-022-00698-3. Epub 2022 Nov 7. PMID: 36344766; PMCID: PMC9640855. 4(12): 1847, December 2022.

19. Ali A, Ortega-Legaspi JM: Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension? Ann Palliat Med. 2022 Oct;11(10):3040-3042. doi: 10.21037/apm-22-1073. PMID: 36367003. 11(10): 3040, October 2022.